Patents by Inventor Rajiv R. MOHAN

Rajiv R. MOHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156783
    Abstract: Provided herein are compositions suitable for treating chemically induced eye damage comprising (a) a nonsteroidal anti-inflammatory drug (NSAID), (b) a histone deacetylase (HDAC) inhibitor and (c) an angiotensin converting enzyme (ACE) inhibitor and, optionally, (d) a water-soluble vitamin. Methods of using provided compositions to treat ocular toxicity and corneal damage following exposure to chemical agents (e.g., mustard gas) are also provided.
    Type: Application
    Filed: December 20, 2023
    Publication date: May 16, 2024
    Applicants: The Curators of the University of Missouri, The United States Government as Represented by the Department of Veterans Affairs
    Inventor: Rajiv R. Mohan
  • Publication number: 20210128526
    Abstract: Provided herein are compositions suitable for treating chemically induced eye damage comprising (a) a nonsteroidal anti-inflammatory drug (NSAID), (b) a histone deacetylase (HDAC) inhibitor and (c) an angiotensin converting enzyme (ACE) inhibitor and, optionally, (d) a water-soluble vitamin. Methods of using provided compositions to treat ocular toxicity and corneal damage following exposure to chemical agents (e.g., mustard gas) are also provided.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 6, 2021
    Inventor: RAJIV R. MOHAN
  • Publication number: 20200030263
    Abstract: Disclosed is a method of promoting wound healing with reduced scarring after glaucoma filtration surgery in a mammalian subject in need thereof, which involve the use of a HDAC inhibitor (HDACi), such as, but not limited to, suberoylanilide hydroxamic acid (SAHA).
    Type: Application
    Filed: October 8, 2019
    Publication date: January 30, 2020
    Inventor: Rajiv R. Mohan
  • Publication number: 20180369172
    Abstract: Disclosed is a method of promoting wound healing with reduced scarring after glaucoma filtration surgery in a mammalian subject in need thereof, which involve the use of a HDAC inhibitor (HDACi), such as, but not limited to, suberoylanilide hydroxamic acid (SAHA).
    Type: Application
    Filed: June 22, 2018
    Publication date: December 27, 2018
    Inventor: Rajiv R. MOHAN